IMVT
Price
$16.42
Change
+$1.22 (+8.03%)
Updated
Apr 2 closing price
Capitalization
2.79B
55 days until earnings call
KYMR
Price
$26.36
Change
+$1.12 (+4.44%)
Updated
Apr 2 closing price
Capitalization
1.71B
28 days until earnings call
Ad is loading...

IMVT vs KYMR

Header iconIMVT vs KYMR Comparison
Open Charts IMVT vs KYMRBanner chart's image
Immunovant
Price$16.42
Change+$1.22 (+8.03%)
Volume$3.71M
Capitalization2.79B
Kymera Therapeutics
Price$26.36
Change+$1.12 (+4.44%)
Volume$717.33K
Capitalization1.71B
IMVT vs KYMR Comparison Chart
Loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMVT vs. KYMR commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and KYMR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IMVT: $16.42 vs. KYMR: $26.36)
Brand notoriety: IMVT and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 216% vs. KYMR: 116%
Market capitalization -- IMVT: $2.79B vs. KYMR: $1.71B
IMVT [@Biotechnology] is valued at $2.79B. KYMR’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • IMVT’s TA Score: 4 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IMVT and KYMR are a good buy in the short-term.

Price Growth

IMVT (@Biotechnology) experienced а -8.22% price change this week, while KYMR (@Biotechnology) price change was -13.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.55%. For the same industry, the average monthly price growth was -9.63%, and the average quarterly price growth was -13.98%.

Reported Earning Dates

IMVT is expected to report earnings on May 28, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-7.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($2.79B) has a higher market cap than KYMR($1.71B). IMVT (-33.710) and KYMR (-34.477) have similar YTD gains . KYMR has higher annual earnings (EBITDA): -216.24M vs. IMVT (-404.87M). KYMR has more cash in the bank: 489M vs. IMVT (375M). IMVT has less debt than KYMR: IMVT (23K) vs KYMR (87.8M). KYMR has higher revenues than IMVT: KYMR (47.1M) vs IMVT (0).
IMVTKYMRIMVT / KYMR
Capitalization2.79B1.71B163%
EBITDA-404.87M-216.24M187%
Gain YTD-33.710-34.47798%
P/E RatioN/AN/A-
Revenue047.1M-
Total Cash375M489M77%
Total Debt23K87.8M0%
TECHNICAL ANALYSIS
Technical Analysis
IMVTKYMR
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHRAX18.77N/A
N/A
Virtus Duff & Phelps Real Estate Secs A
IRGFX20.02N/A
N/A
Macquarie Small Cap Growth R6
DSHFX11.43N/A
N/A
Brinker Capital Destinations Shelter I
VWENX72.56N/A
N/A
Vanguard Wellington™ Admiral™
MSHLX39.70N/A
N/A
Morgan Stanley Inst Growth L

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+8.03%
ROIV - IMVT
53%
Loosely correlated
+2.34%
BRNS - IMVT
48%
Loosely correlated
-5.55%
RCKT - IMVT
46%
Loosely correlated
+8.43%
DNLI - IMVT
44%
Loosely correlated
+11.80%
IDYA - IMVT
41%
Loosely correlated
+10.70%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+4.46%
CCCC - KYMR
59%
Loosely correlated
+5.92%
IMNM - KYMR
50%
Loosely correlated
+7.19%
NRIX - KYMR
50%
Loosely correlated
+8.69%
ATXS - KYMR
50%
Loosely correlated
+2.22%
RCKT - KYMR
49%
Loosely correlated
+8.43%
More